全文获取类型
收费全文 | 972篇 |
免费 | 44篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 42篇 |
妇产科学 | 12篇 |
基础医学 | 94篇 |
口腔科学 | 21篇 |
临床医学 | 148篇 |
内科学 | 235篇 |
皮肤病学 | 21篇 |
神经病学 | 102篇 |
特种医学 | 23篇 |
外科学 | 123篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 37篇 |
眼科学 | 14篇 |
药学 | 78篇 |
中国医学 | 2篇 |
肿瘤学 | 33篇 |
出版年
2023年 | 7篇 |
2022年 | 10篇 |
2021年 | 48篇 |
2020年 | 23篇 |
2019年 | 40篇 |
2018年 | 46篇 |
2017年 | 26篇 |
2016年 | 27篇 |
2015年 | 37篇 |
2014年 | 43篇 |
2013年 | 60篇 |
2012年 | 74篇 |
2011年 | 74篇 |
2010年 | 50篇 |
2009年 | 33篇 |
2008年 | 62篇 |
2007年 | 66篇 |
2006年 | 65篇 |
2005年 | 43篇 |
2004年 | 27篇 |
2003年 | 31篇 |
2002年 | 11篇 |
2001年 | 4篇 |
2000年 | 12篇 |
1999年 | 6篇 |
1998年 | 2篇 |
1996年 | 6篇 |
1995年 | 2篇 |
1993年 | 5篇 |
1992年 | 4篇 |
1991年 | 7篇 |
1990年 | 5篇 |
1989年 | 11篇 |
1988年 | 6篇 |
1987年 | 2篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 5篇 |
1978年 | 2篇 |
1976年 | 1篇 |
1975年 | 4篇 |
1972年 | 2篇 |
1971年 | 2篇 |
1970年 | 7篇 |
1969年 | 2篇 |
1968年 | 3篇 |
1967年 | 3篇 |
1966年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有1022条查询结果,搜索用时 15 毫秒
1.
Pratipal Singh Vivek Vijjan Manu Gupta Deepak Dubey Aneesh Srivastava 《International journal of urology》2007,14(6):558-560
Congenital thoracic ectopic kidney is a very rare developmental anomaly and the rarest form of all ectopic kidneys. It is usually asymptomatic and discovered incidentally on routine chest radiography. Herein we reported the first case of staghorn stone in a thoracic kidney managed successfully by percutaneous nephrolithotomy. 相似文献
2.
Ajit Sood Vandana Midha Neena Sood Manu Bansal 《Indian journal of gastroenterology》2006,25(6):283-285
BACKGROUND: The treatment of hepatitis C virus (HCV)-related cirrhosis is difficult due to high frequency of adverse effects. We retrospectively reviewed the case records of patients with HCV cirrhosis to evaluate the efficacy and tolerability of pegylated (peg) interferon and ribavirin treatment in these patients. METHODS: Medical records of 28 patients with HCV-related compensated cirrhosis were reviewed. The treatment protocol was a combination therapy of peg interferon alfa-2b (1 microg/Kg/week) plus oral ribavirin (10-12 mg/Kg/day). Primary endpoint was sustained virological response, with additional endpoints of drug tolerance, clinical or biochemical worsening and death. RESULTS: End-of-treatment virlogic response was seen in 24 of 28 patients (85%) and sustained virologic response in 15 of 28 (53%) patients. Biochemical end-of-treatment response and sustained response were seen in 20 and 16 patients (71% and 57%), respectively. Treatment had to be stopped in 3 patients due to decompensation of liver status in two and drug intolerance in one, while dose modification was required in two patients. CONCLUSIONS: Combination therapy with peg interferon plus ribavirin seems effective in patients with liver cirrhosis. High relapse rate, poor biochemical recovery and possibility of decompensation are issues that need to be kept in mind. 相似文献
3.
A Kh Kogan N I Losev Iu V Biriukov V A Sandrikov A B Tsypin M Al'-Khadidi B M Manu?lov A L Syrkin G S Krotovski? A P Pogromov 《Patologicheskaia fiziologiia i èksperimental'naia terapiia》1991,(1):46-50
Studies conducted in the clinic (in patients with cardiac diseases) and experiments (performed on intact dogs) by means of the hemiluminescent method and the nitroblue tetrazolium test showed that the lungs, in distinction to other organs (heart and others), have a stimulating effect on the generation of active oxygen forms (AOF) by the leukocytes. In this way the lungs may probably play a double role in the organism: potentiate its defence (by intensifying the microbicidal activity of the phagocytes) and facilitate damage (by secretion of AOF by the phagocytes beyond them--into the tissues); the resultant effect depends on the balance of these two types of action. In carcinoma of the lung the stimulating effect of its involved lobe (part) on the leukocytes diminishes. 相似文献
4.
5.
6.
Hassan AB Nikitina-Zake L Padyukov L Karlsson G Gupta M Lundberg IE Sanjeevi CB 《Human immunology》2003,64(2):290-296
In order to investigate major histocompatibility complex (MHC) class I chain-related gene A (MICA), tumor necrosis factor (TNFa), -308TNFA, and human leukocyte antigen (HLA-DR/DQ) polymorphisms in mixed connective tissue disease (MCTD), we analyzed 24 patients and 229 healthy controls from Sweden. MICA and TNFa typing was performed by polymerase chain reaction (PCR) and genotyping. HLA-DR and -DQ were genotyped using PCR-sequence specific primers (PCR-SSP) and PCR-sequence-specific oligonucleotide probe (PCR-SSOP), respectively. For analysis of -308TNFA polymorphisms we performed PCR with restriction endonuclease enzymes. We found that the MICA5.1-5.1 genotype was positively associated with MCTD. Shared epitope genes (DRB1*01 and DRB1*04) were also significantly positively associated with MCTD. Polymorphism of -308TNFA was not differently distributed in MCTD patients compared with controls. Furthermore, we demonstrated that frequencies of three estimated haplotypes were increased in MCTD patients compared with controls. Interestingly, the haplotype with MICA allele 4 together with DRB1*04 and TNF1 alleles gives the most specific pattern for MCTD patients compared with controls. Our study demonstrates a clear contribution of HLA loci in susceptibility to MCTD in the Swedish population. Susceptibility to MCTD may be linked to the MICA4/HLA-DRB1*04/TNF1 haplotype and MICA 5.1-5.1 genotype. Mixed connective tissue disease was also associated with shared epitope genes, which in RA has been associated with a more severe disease. Whether these genotypes affect the clinical phenotype of MCTD needs to be determined. 相似文献
7.
P Manu D A Matthews T J Lane H Tennen V Hesselbrock R Mendola G Affleck 《Journal of affective disorders》1989,17(2):165-172
The prevalence of mood disorders among patients with chronic fatigue was examined in a group of 100 adults who had experienced fatigue symptoms for an average of 13 years. Patients received a comprehensive history, physical and laboratory evaluation and completed the National Institute of Mental Health Diagnostic Interview Schedule and the Beck Depression Inventory (BDI). Among 44 patients with depressive illness, the onset of their first depressive episode was strongly associated with and preceded the onset of chronic fatigue. The BDI, fatigue history, demographic factors, and findings from the physical examination and laboratory had only modest success in discriminating those patients with depressive illness from other patients. We conclude that depressive illness is an important precursor of chronic fatigue. 相似文献
8.
Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. 总被引:2,自引:0,他引:2
Eliane Gluckman Vanderson Rocha Irina Ionescu Marc Bierings Richard E Harris John Wagner Joanne Kurtzberg Martin A Champagne Carmem Bonfim Marco Bittencourt Philip Darbyshire Manuél-Nicolas Fernandez Franco Locatelli Ricardo Pasquini 《Biology of blood and marrow transplantation》2007,13(9):1073-1082
We retrospectively analyzed results of unrelated cord blood transplantation (UCBT) in 93 Fanconi anemia (FA) patients. Median age at transplantation was 8.6 years (1-45). The units transplanted were HLA-A, -B, or -DRB1 identical in 12 cases, 1 HLA mismatch in 35 cases, and 2 or 3 HLA differences in 45 cases. The median number of nucleated cells (NC) and CD34+ cells infused of recipient weight was 4.9x10(7)/kg and 1.9x10(5)/kg, respectively. Participating centers selected the preparative regimen of their choice, in 57 patients (61%), it included Fludarabine. Graft-versus-host disease (GVHD) prophylaxis consisted mostly of cyclosporine with prednisone. Cumulative incidence (CI) of neutrophil recovery was 60+/-5% at day +60. In multivariate analysis, Fludarabine containing regimen and NC infused>or=4.9x10(7)/kg were associated with higher probability of recovery. CI of grade II-IV acute and of chronic GVHD (aGVHD, cGVHD) was 32%+/-5% and 16%+/-4%, respectively. Overall survival (OS) was 40%+/-5%. In multivariate analysis, factors associated with favorable outcome were use of Fludarabine in the conditioning regimen, number of NC infused>or=4.9x10(7)/kg, and negative cytomegalovirus (CMV) serology in the recipient. In conclusion, factors easily modifiable such as donor selection and a Fludarabine-containing regimen can considerably improve survival in FA patients given a UCBT. These data are the basis for designing prospective protocols. 相似文献
9.
Ravi Ramalingam K. K. Ramalingairr A. V. Ramesh S. Mahesh Prabhu Manu Vergis N. Ahilasamy 《Indian journal of otolaryngology and head and neck surgery》2003,55(4):294-295
The incidence of Papillary Thyroid Carcinoma in a Thyroglossal Cyst is rare. Only about 160 cases have been reported in the
last 85 years. We report a case of Thyroglossal Cyst who underwent Sistrunk ’s Operation. The Cyst was reported to
contain a focus of papillary thyroid carcinoma. In the absence of metastases in thyroid gland and neck nodes, only thyroid
suppression with Thyroxine was given. After I year of follow-up there are no metastases. The importance of Sistrunk’s
operation lies not only in complete removal of Thyroglossal Cyst but also in management of small foci of Papillary thyroid
Carcinoma. 相似文献
10.
Effect of Punarnavine on the cell-mediated immune (CMI) response in metastatic condition was studied using C57BL/6 mice model. Administration of Punarnavine enhanced Natural Killer (NK) cell activity, antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent complement mediated cytotoxicity (ACC) and the activity was observed in treated group much earlier compared to the metastatic tumor-bearing control. Production of cytokines such as IL-2 and IFN-γ were significantly enhanced by the administration of Punarnavine compared to the untreated metastatic tumor-bearing control. Peaks of pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α were significantly lowered by Punarnavine administration compared to metastatic control. The level and expression of TIMP-1 was also enhanced by the administration of Punarnavine compared to metastatic tumor bearing control. These results indicate Punarnavine could enhance the immune response against metastatic progression of B16F-10 melanoma cells in mice. 相似文献